Rechallenge with gefitinib following severe druginduced hepatotoxicity in a patient with advanced nonsmall cell lung cancer: A case report and literature review

Author：              

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.3, 2014-01, pp. : 878-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Eyelash trichomegaly following treatment with erlotinib in a nonsmall cell lung cancer patient: A case report and literature review

By Wang ShanBing   Lei KaiJian   Liu JiaPei   Jia YuMing  

Oncology Letters, Vol. 10, Iss. 2, 2015-08 ,pp. : 954-956

Spandidos Publications

Access to resources Recommend Favorite

Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature

By        

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2419-2421

Spandidos Publications

Access to resources Recommend Favorite

Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature

By        

Experimental and Therapeutic Medicine, Vol. 11, Iss. 1, 2016-01 ,pp. : 197-200

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

High efficacy of gefitinib in the treatment of EGFR mutationpositive advanced nonsmall cell lung adenocarcinoma: A case report

By    

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1320-1322

Spandidos Publications

Access to resources Recommend Favorite